期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Sequential Combination Diuretic-Therapy for Massive Fluid Overload in Furosemide-Refractory Patients with Diabetic Kidney Disease
1
作者 Kamel El-Reshaid Shaikha Al-Bader 《Open Journal of Nephrology》 2021年第2期265-272,共8页
Patients with renal disease are at risk of fluid overload which escalates as the disease progresses. In the present study, we evaluated the efficacy of sequential combination diuretic-therapy (SCDT) in management of m... Patients with renal disease are at risk of fluid overload which escalates as the disease progresses. In the present study, we evaluated the efficacy of sequential combination diuretic-therapy (SCDT) in management of massive fluid overload in Furosemide-refractory renal patients. The added diuretics were Spironolactone 25 mg daily for 3 days, to those without risk of hyperkalemia, followed by Hydrochlorothiazide 25 mg/Metolazone 5 mg daily for 3 more days. Excluded patients were those with 1) acute renal disease, 2) echocardiographic evidence of: a) left ventricular ejection fraction < 40%, b) significant stenotic or incompetent valvular disease, c) ASD or VSD, d) significant pericardial disease, and 3) significant limb venous disease or on drugs likely to cause limb-oedema. To assess the extent of fluid overload;clinical examination was complemented with radiological imaging as well as echocardiographic measurement of systolic pulmonary arterial pressure (sPAP). SCDT led to significant symptomatic, clinical, and radiological improvement of fluid overload without significant side effects. The latter were limited to hyperkalemia and hyponatremia which improved with dietary compliance. Moreover, hyperkalemia improved after subsequent addition of Thiazide/Metolazone. SCDT led to significant (p < 0.001) increase in fractional excretion of sodium and decrease in body weight and sPAP. In conclusion;SCDT is a safe and efficacious measure to control fluid overload in patients with renal diseases. 展开更多
关键词 aldactone Diabetes Mellitus ECHOCARDIOGRAPHY Fluid Overload FUROSEMIDE HYDROCHLOROTHIAZIDE Kidney Disease Metolazone SPIRONOLACTONE
下载PDF
Analysis of spironolactone residues in industrial wastewater and in drug formulations by cathodic stripping voltammetry
2
作者 M.S.El-Shahawi A.S.Bashammakh +1 位作者 A.A.Al-Sibaai E.A.Bahaidarah 《Journal of Pharmaceutical Analysis》 SCIE CAS 2013年第2期137-143,共7页
The redox behavior of spironolactone(SP) drug in Britton-Robinson(BR) buffer of pH 2-11 was investigated by differential pulse cathodic stripping voltammetry(DPCSV) and cyclic voltammetry(CV) at hanging mercur... The redox behavior of spironolactone(SP) drug in Britton-Robinson(BR) buffer of pH 2-11 was investigated by differential pulse cathodic stripping voltammetry(DPCSV) and cyclic voltammetry(CV) at hanging mercury dropping electrode(HMDE).At pH 9-10.5,the DPCSV of SP drug showed two cathodic peaks at1.15 and1.38 V at the HMDE vs.Ag/AgCl reference electrode.In the CV,at pH 9-10,the dependence of the cathodic peak current,Ip,c and peak potential,Ep,c of the second peak(Ep,c2) on the scan rate(n) and on the depolizer(SP) concentrations was typical of an electrode coupled(EC) chemical reaction type mechanism.The plot of Ip,cat 1.380 V of the DPCSV vs.SP concentration at pH 9 was linear over the concentration range of 1.2×1010-9.6×107 M.The lower limit of detection(LLOD) and limit of quantification(LOQ) of the drug were 1.1×1011 and 4.14×1011 M,respectively.The method was successfully applied for the analysis of SP residues in industrial wastewater,in pure form(98.273.1%) and in drug formulations e.g.Aldactones tablet(98.3572.9%).The method was validated by comparison with HPLC and the official data methods. 展开更多
关键词 Spironolactone drug residue Cathodic stripping voltammetry Wastewater aldactones tablets Electrode mechanism
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部